We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » J&J Begins Largest Global Phase 3 COVID-19 Vaccine Trial to Date
J&J Begins Largest Global Phase 3 COVID-19 Vaccine Trial to Date
Johnson and Johnson (J&J) yesterday became the fourth drugmaker to begin a large-scale phase 3 trial of a COVID-19 vaccine candidate — and it will be the largest late-stage trial of a COVID-19 vaccine to date.